September 20, 2019 11:24 AM EDT
Pharma

Astel­las' AML drug wins over CHMP — strength­en­ing lead on Dai­ichi Sankyo

Amber Tong

Less than a year af­ter scor­ing a fast FDA OK for its pi­o­neer­ing acute myeloid leukemia drug gilter­i­tinib, Astel­las has snapped up a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

FDA is poised to pull Ocali­va as ad­comm doc­u­ments ques­tion post-ap­proval study re­sults

FDA crit­i­cizes Ab­b­Vie's 'mis­lead­ing' ad with Ser­e­na Williams

Roche says its Car­mot-ac­quired obe­si­ty pill is ef­fec­tive in ear­ly study

House pass­es Biose­cure Act, send­ing Chi­nese biotech ban to Sen­ate

No­vo Nordisk's long­stand­ing GLP-1 re­duced BMI by 7% in chil­dren in Phase 3 tri­al

CVS says it won't cor­rect con­gres­sion­al tes­ti­mo­ny

A service from the Financial Times